Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Tariq Zuheir Kewan, MD, Shafia Rahman, MBBS, Fahrettin Covut, MD, Ramsha Ahmed, MD, Seba Hasan, Yihong Zhou, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3683.

https://doi.org/10.1182/blood-2019-131758

Published: 2019

Journal Articles

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

Jeffrey I. Zwicker, MD, David S. Lessen, MD, Philomena Colucci, DO, MS, Dilan Paranagama, PhD, Michael R. Grunwald, MD

Blood (2019) 134 (Supplement_1): 168.

https://doi.org/10.1182/blood-2019-123835

Published: 2019

Journal Articles

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Leonard Naymagon, MD, Douglas Tremblay, MD, Nicole Zubizarreta, MPH, Erin Moshier, MS, Thomas Schiano, MD, John Mascarenhas, MD

Blood (2019) 134 (Supplement_1): 1154.

https://doi.org/10.1182/blood-2019-124042

Published: 2019

Journal Articles

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

Jai N Patel, PharmD, BCOP, Megan Helena Jagosky, MD, Myra M Robinson, MSPH, Daniel Slaughter, Justin Arnall, PharmD, CPP, BCOP, Ashley Matusz-Fisher, MD, Manisha Bhutani, MD, Peter M. Voorhees, MD, Saad Z. Usmani, MD

Blood (2018) 132 (Supplement 1): 4814.

https://doi.org/10.1182/blood-2018-99-118283

Published: 2018

Journal Articles

The In Vivo infected Clones Have Mixed Immunophenotype and Malignant Transformation Is Characterized By Dominant Growth of CD4+CCR4+CD26-CD7- Cells in Human T Lymphotropic Virus Type 1 Infection

Huseini Hatimbhai Kagdi, MD PhD MBBS, FRCPath, MRCP, Graham Phillip Taylor, MB ChB, DSc, FRCP, FHEA

Blood (2018) 132 (Supplement 1): 2844.

https://doi.org/10.1182/blood-2018-99-111440

Published: 2018

Journal Articles

HLH: watch and wait, or act and cure ?

Kenneth L. McClain, Caridad A. Martinez

Blood (2018) 132 (19): 2005–2006.

https://doi.org/10.1182/blood-2018-09-873646

Published: 2018

Journal Articles

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

Blood (2018) 132 (19): 2088–2096.

https://doi.org/10.1182/blood-2018-01-827485

Published: 2018

Includes: Supplemental data

Journal Articles

NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages

Juhi Bagaitkar, Jing Huang, Melody Yue Zeng, Nancy K. Pech, Darlene A. Monlish, Lizet J. Perez-Zapata, Irina Miralda, Laura G. Schuettpelz, Mary C. Dinauer

Blood (2018) 131 (21): 2367–2378.

https://doi.org/10.1182/blood-2017-09-809004

Published: 2018

Includes: Supplemental data

Journal Articles

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Blood (2017) 130 (Supplement 1): 3564.

https://doi.org/10.1182/blood.V130.Suppl_1.3564.3564

Published: 2017

Journal Articles

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Aditi Khandelwal, MDM, Syed Mahamad, BSc candidate, Jerome M. Teitel, MD, Michelle Sholzberg, MDM, MSc

Blood (2016) 128 (22): 1418.

https://doi.org/10.1182/blood.V128.22.1418.1418

Published: 2016

Journal Articles

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Hiroshi Deguchi, Yajnavalka Banerjee, Sunia Trauger, Gary Siuzdak, Ewa Kalisiak, José A. Fernández, Linh Hoang, Minerva Tran, Subramanian Yegneswaran, Darlene J. Elias, John H. Griffin

Blood (2015) 126 (13): 1595–1600.

https://doi.org/10.1182/blood-2015-03-636761

Published: 2015

Includes: Supplemental data

Journal Articles

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells

Min Lu, Lijuan Xia, Yen-Chun Liu, Tsivia Hochman, Laetizia Bizzari, Daniel Aruch, Jane Lew, Rona Weinberg, Judith D. Goldberg, Ronald Hoffman

Blood (2015) 126 (8): 972–982.

https://doi.org/10.1182/blood-2014-12-618595

Published: 2015

Includes: Supplemental data

Journal Articles

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Hiroshi Deguchi, MD PhD, Yajnavalka Banerjee, PhD, Gary Siuzdak, PhD, Sunia Trauger, PhD, Ewa Kalisiak, PhD, Jose A. Fernandez, MD PhD, Linh Hoang, Minerva Tran, Subramanian Yegneswaran, PhD, Darlene J Elias, MD, John H. Griffin, PhD

Blood (2014) 124 (21): 2797.

https://doi.org/10.1182/blood.V124.21.2797.2797

Published: 2014

Journal Articles

Immune Exhaustion and 2B4 Expression in Human T-Cell Lymphotropic Virus Type 1(HTLV-1) Infection

Ezinne Chioma Chibueze, MD, Yohann White, MD, PhD, Makoto Yoshimitsu, MD PhD, Tomohiro Kozako, PhD, Shinsuke Suzuki, MD, PhD, Kakushi Matsushita, MD, Kimiharu Uozumi, MD, PhD, Naomichi Arima, MD, PhD

Blood (2012) 120 (21): 4807.

https://doi.org/10.1182/blood.V120.21.4807.4807

Published: 2012

Journal Articles

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

Yoshimi Enose-Akahata, Anna Abrams, Kory R. Johnson, Elizabeth M. Maloney, Steven Jacobson

Blood (2012) 119 (12): 2829–2836.

https://doi.org/10.1182/blood-2011-11-390807

Published: 2012

Journal Articles

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

Andrew Hodson, MD, Barbara Bain, FRCPath, MB, Paul Fields, MD, PhD, Graham Talyor, MD

Blood (2010) 116 (21): 4167.

https://doi.org/10.1182/blood.V116.21.4167.4167

Published: 2010

Journal Articles

LOX-1 as a natural IFN-α–mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells

Stefania Parlato, Giulia Romagnoli, Francesca Spadaro, Irene Canini, Paolo Sirabella, Paola Borghi, Carlo Ramoni, Ilaria Filesi, Silvia Biocca, Lucia Gabriele, Filippo Belardelli

Blood (2010) 115 (8): 1554–1563.

https://doi.org/10.1182/blood-2009-07-234468

Published: 2010

Journal Articles

Target Epitopes of Human T Lymphotropic Virus 1 Recognized by Class I MHC-Restricted Cytotoxic T Lymphocytes in HAM/TSP Patients and Infected Patients with Autoimmune Disorders.

Tomohiro Kozako, PhD, Masaki Akimoto, MD, PhD, Yohann White, MD, Shingo Toji, Kakushi Matsushita, MD, PhD, Ryuji Kubota, MD, PhD, Shuji Izumo, MD, PhD, Shinsuke Suzuki, MD, PhD, Kimiharu Uozumi, MD, Hiroshi Shimeno, PhD, Shinji Soeda, PhD, Naomichi Arima, MD, PhD

Blood (2009) 114 (22): 2660.

https://doi.org/10.1182/blood.V114.22.2660.2660

Published: 2009

Journal Articles

Increased Frequency of HTLV-1 Tax Specific CD8+ Regulatory T-Cells in HTLV-1 Infected Individuals.

Yohann White, MBBS, BMedSc, Makoto Yoshimitsu, MD, Tomohiro Kozako, PhD, Kakushi Matsushita, MD, PhD, Kimiharu Uozumi, MD, Shinsuke Suzuki, MD, PhD, Hiroki Kofune, BSc, Naomichi Arima, MD, PhD

Blood (2009) 114 (22): 3676.

https://doi.org/10.1182/blood.V114.22.3676.3676

Published: 2009

Journal Articles

Severe loss of invariant NKT cells exhibiting anti–HTLV-1 activity in patients with HTLV-1–associated disorders

Kazuko Azakami, Tomoo Sato, Natsumi Araya, Atae Utsunomiya, Ryuji Kubota, Kenshi Suzuki, Daisuke Hasegawa, Toshihiko Izumi, Hidetoshi Fujita, Satoko Aratani, Ryoji Fujii, Naoko Yagishita, Hajime Kamijuku, Takuro Kanekura, Ken-ichiro Seino, Kusuki Nishioka, Toshihiro Nakajima, Yoshihisa Yamano

Blood (2009) 114 (15): 3208–3215.

https://doi.org/10.1182/blood-2009-02-203042

Published: 2009

Includes: Supplemental data

NARROW

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Risk of Hemorrhage in Patients with Polycythemia Vera Exposed to Aspirin in Combination with Anticoagulants: Results of a Prospective, Multicenter, Observational Cohort Study (REVEAL)

The Use of Direct Oral Anticoagulants in Non-Cirrhotic Portal Vein Thrombosis

Risk Factors for Thromboembolism (TE) in Multiple Myeloma (MM) Patients (pts) Treated with Immunomodulatory Agents (IMiDs) Plus Dexamethasone (dex)

The In Vivo infected Clones Have Mixed Immunophenotype and Malignant Transformation Is Characterized By Dominant Growth of CD4+CCR4+CD26-CD7- Cells in Human T Lymphotropic Virus Type 1 Infection

HLH: watch and wait, or act and cure ?

Treatment dilemmas in asymptomatic children with primary hemophagocytic lymphohistiocytosis

NADPH oxidase activation regulates apoptotic neutrophil clearance by murine macrophages

Treatment Dilemmas in Asymptomatic Children with Primary Haemophagocytic Lymphohistiocytosis

Surgery in Patients with Factor VIII Inhibitors: A Retrospective Case Series at the Largest Canadian Hemophilia Care Centre

Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data

Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells

Acylcarnitines Are Novel Anticoagulant Lipids That Target Factor Xa and That Are Reduced in Plasma of Venous Thrombosis Patients Based on Untargeted and Targeted Metabolomics

Immune Exhaustion and 2B4 Expression in Human T-Cell Lymphotropic Virus Type 1(HTLV-1) Infection

Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica

Smouldering Adult T-Cell Leukaemia/Lymphoma (ATLL) Is Not Associated with An Increased Risk of Aggressive ATLL In HTLV-1 Positive Patients

LOX-1 as a natural IFN-α–mediated signal for apoptotic cell uptake and antigen presentation in dendritic cells

Target Epitopes of Human T Lymphotropic Virus 1 Recognized by Class I MHC-Restricted Cytotoxic T Lymphocytes in HAM/TSP Patients and Infected Patients with Autoimmune Disorders.

Increased Frequency of HTLV-1 Tax Specific CD8+ Regulatory T-Cells in HTLV-1 Infected Individuals.

Severe loss of invariant NKT cells exhibiting anti–HTLV-1 activity in patients with HTLV-1–associated disorders

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only